Document Detail


Osteogenin, a bone morphogenetic protein, adsorbed on porous hydroxyapatite substrata, induces rapid bone differentiation in calvarial defects of adult primates.
MedLine Citation:
PMID:  1325064     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Osteogenin, a bone morphogenetic protein, in conjunction with insoluble collagenous bone matrix initiates local endochondral bone differentiation by induction in vivo. This study, by exploiting the affinity of native osteogenin for hydroxyapatite, was designed to construct a delivery system for the expression of the biologic activity of osteogenin in nonhealing calvarial defects of adult primates. After exposure of the calvaria, 64 cranial defects, 25 mm in diameter, were prepared in 16 adult male baboons (Papio ursinus). Defects were implanted with disks of porous nonresorbable and resorbable hydroxyapatite substrata obtained after hydrothermal conversion of calcium carbonate exoskeletons of corals. In each animal, one disk of each hydroxyapatite preparation was treated with osteogenin isolated and purified from baboon bone matrix after sequential chromatography on heparin-Sepharose, hydroxyapatite, and Sephacryl S-200 gel filtration columns. The remaining two defects were implanted with one disk of each hydroxyapatite preparation without osteogenin as control. Histomorphometry on decalcified sections prepared on days 30 and 90 showed superior osteogenesis in osteogenin-treated nonresorbable hydroxyapatite specimens as compared with controls. On day 90, substantial bone formation also had occurred in control nonresorbable hydroxyapatite specimens. On day 90, but not on day 30, significantly greater amounts of bone had formed in osteogenin-treated resorbable specimens as compared with resorbable controls. Overall, resorbable substrata performed poorly when compared with nonresorbable substrata, perhaps due to a premature dissolution of the implants. These results provide evidence that the biologic activity of osteogenin can be restored and delivered by a substratum other than the organic collagenous matrix, inducing rapid bone differentiation in calvarial defects of adult nonhuman primates. The adsorption strategy of osteogenin on porous inorganic nonimmunogenic substrata may help to design appropriate osteogenic delivery systems for craniofacial and orthopedic applications in humans.
Authors:
U Ripamonti; S S Ma; B van den Heever; A H Reddi
Related Documents :
21830854 - Enhanced healing of rat calvarial defects with sulfated chitosan coated cdha/bmp-2 scaf...
16857254 - Freeze casting of hydroxyapatite scaffolds for bone tissue engineering.
12427484 - Effect of fk506 on osteoinduction by recombinant human bone morphogenetic protein-2.
7006134 - Effects of bone wax on bacterial clearance.
17882114 - Current understanding of osteoporosis according to the position of the world health org...
2766604 - Axial loading studies of unstable intertrochanteric fractures of the femur.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Plastic and reconstructive surgery     Volume:  90     ISSN:  0032-1052     ISO Abbreviation:  Plast. Reconstr. Surg.     Publication Date:  1992 Sep 
Date Detail:
Created Date:  1992-09-30     Completed Date:  1992-09-30     Revised Date:  2011-02-16    
Medline Journal Info:
Nlm Unique ID:  1306050     Medline TA:  Plast Reconstr Surg     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  382-93     Citation Subset:  AIM; IM    
Affiliation:
Medical Research Council, University of the Witwatersrand, Johannesburg, South Africa.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adsorption
Animals
Biocompatible Materials / chemistry
Biodegradation, Environmental
Biological Assay
Bone Morphogenetic Protein 3
Bone Morphogenetic Proteins*
Bone Resorption / pathology
Cephalometry
Craniotomy
Durapatite
Growth Substances / administration & dosage,  chemistry,  isolation & purification,  therapeutic use*
Hydroxyapatites* / chemistry
Male
Osteoblasts / pathology
Osteogenesis / drug effects*
Papio
Porosity
Prostheses and Implants*
Proteins / administration & dosage,  chemistry,  isolation & purification,  therapeutic use*
Rats
Skull / drug effects,  pathology,  surgery*
Surface Properties
Wound Healing
Chemical
Reg. No./Substance:
0/BMP3 protein, human; 0/Biocompatible Materials; 0/Bmp3 protein, rat; 0/Bone Morphogenetic Protein 3; 0/Bone Morphogenetic Proteins; 0/Growth Substances; 0/Hydroxyapatites; 0/Proteins; 1306-06-5/Durapatite

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Conjugative plasmids in Bordetella avium.
Next Document:  Breast reconstruction in women treated with radiation therapy for breast cancer: cosmesis, complicat...